Detected on Saturday 31 October, 07h27
Biosynex's US subsidiary obtains $5.7 million funding
Chembio Diagnostic Systems, US subsidiary of the Alsatian Biosynex based in Illkirch-Graffenstaden, has obtained $5.7 million from the US Department of Health for work on biological threats.
In brief
Economy event (severity: info) in Illkirch-Graffenstaden (Bas-Rhin), first detected on 31 October 2026 at 07:27. Reported by 1 source (1 article), last updated on 31 October 2026 at 07:27.
- Category
- Economy
- Severity
- Info
- Place
- 67 Bas-RhinIllkirch-Graffenstaden
- Detected
- 31 Oct, 07h27
- Updated
- 31 Oct, 07h27
- Reference
- no.5528
1 article · 1 source · 1 bord sur 3 · outlets: left 0, centre 1, right 0
Angle comparison
A comparison is written as soon as the event is covered by at least two sides (left, centre, right).
Lire les sources · 1 article, 1 source
- 07h27Dernières Nouvelles d'AlsaceCentreWire31 OctAlsace. Menaces biologiques : un financement de 5,7 millions de dollars pour une filiale américaine de Biosynex
L’entreprise américaine Chembio Diagnostic Systems, filiale à 100 % de la société alsacienne Biosynex, basée à Illkirch-Graffenstaden, a obtenu un financement de 5,7 millions de dollars, de la part du ministère américain de la Santé.
Further reading
Reported toll
Amounts cited5,7 millions de dollars
Highest number recorded in 1 article(s), automatically extracted: please check sources.
Organisations cited
Places cited
Keywords
#Biosynex · #biologie · #financement
Go up the thread
Affected departments
People and organisations cited